A Novel, Live-Attenuated Vesicular Stomatitis Virus Vector Displaying Conformationally Intact, Functional HIV-1 Envelope Trimers That Elicits Potent Cellular and Humoral Responses in Mice-Reference-Cited by-同舟云学术

A Novel, Live-Attenuated Vesicular Stomatitis Virus Vector Displaying Conformationally Intact, Functional HIV-1 Envelope Trimers That Elicits Potent Cellular and Humoral Responses in Mice

Published:2014-09-12 Issue:9 Volume:9 Page:e106597
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Rabinovich Svetlana,Powell Rebecca L. R.,Lindsay Ross W. B.,Yuan Maoli,Carpov Alexei,Wilson Aaron,Lopez Mary,Coleman John W.,Wagner Denise,Sharma Palka,Kemelman Marina,Wright Kevin J.,Seabrook John P.,Arendt Heather,Martinez Jennifer,DeStefano Joanne,Chiuchiolo Maria J.,Parks Christopher L.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference104 articles.

1. WHO (2011) Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. Geneva. 233 p.

2. The impact of a partially effective HIV vaccine on a population of intravenous drug users in Bangkok, Thailand: a dynamic model;E Bogard;J Acquir Immune Defic Syndr,2002

3. (2012) The Potential Impact of an AIDS Vaccine in Low- and Middle-Income Countries. IAVI Insights Policy Brief, v. 29. International AIDS Vaccine Initiative.

4. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene;MD Daniel;Science,1992

5. Protective immunity induced by live attenuated simian immunodeficiency virus;RP Johnson;Curr Opin Immunol,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen;Emerging Microbes & Infections;2023-09-07

2. Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV;Vaccines;2023-05-12

3. Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor;Biotechnology Reports;2023-03

4. Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials;Vaccines;2022-09-21

5. Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera;eBioMedicine;2022-08